Feature | August 24, 2012

Varian Establishes Subsidiary in South Korea

August 23, 2012 — Varian Medical Systems is establishing an in-country subsidiary in South Korea. Varian Medical Systems Korea, based in Seoul, will support the launch and rollout of the company's TrueBeam treatment system while, over time, providing a local base for all the company's business units.

"South Korea is a vibrant and growing market and we felt the time was right to establish a local office to provide a higher level of local installation, service and technical support for our customers, particularly the growing number of TrueBeam customers," said Patrick Joda, Varian's worldwide head of customer support services. "Longer term, we intend to use the site for an in-country spare parts bank and potentially as a local language training and education base."

The new office will also provide local support for Seoul-based HDX Corp., which has distributed Varian's products in South Korea for 30 years. HDX remains the primary sales and distribution channel for all Varian's systems in the country.

With more than 100 linear accelerators installed in South Korea, Varian systems comprise 65 percent of the installed base of treatment machines. The country's first TrueBeam system was installed at Asan Hospital in Seoul in February this year and is currently providing advanced radiotherapy and radiosurgery treatments for numerous cancer patients. Several other TrueBeam installations are imminent in the country.

For more information, visit www.varian.com

Related Content

A new hybrid X-ray detector developed by the University of Surrey outperforms commercial devices — and could lead to more accurate cancer therapy.
News | X-Ray | December 03, 2020
December 3, 2020 — A new hybrid X-ray detector deve
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Getty Images

News | Prostate Cancer | December 02, 2020
December 2, 2020 — ...
During active surveillance, prostate cancer is carefully monitored for signs of progression through regular prostate-specific antigen (PSA) screening, prostate exams, imaging, and repeat biopsies.

Getty Images

News | Prostate Cancer | November 18, 2020
November 18, 2020 — ...
Minimizing delays to treatment could improve cancer survival rates, say researchers

Getty Images

News | Radiation Oncology | November 10, 2020
November 10, 2020 — People whose treatment for cancer is delayed by even one month have in many cases a 6 to 13% high